Early research (Phase 1)Study completedNCT01385423
What this trial is testing
Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 26